Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 2.39M | -- | 4.91% | -4.29M | 2026-06-30 |
| Balyasny Asset Management L.P. | 1.79M | -- | 3.68% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 1.22M | -- | 2.51% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 674.6K | -- | 1.39% | +158.4K | 2026-06-30 |
| Lynx1 Capital Management LP | 657.8K | -- | 1.35% | -- | 2026-06-30 |
| Sphera Funds Management Ltd. | 626.8K | -- | 1.29% | -- | 2026-06-30 |
| DC Funds, LP | 589.1K | -- | 1.21% | -- | 2026-06-30 |
| Verdad Advisers, LP | 348.7K | -- | 0.72% | +318.9K | 2026-06-30 |
| Geode Capital Management, LLC | 335.8K | -- | 0.69% | -53.7K | 2026-06-30 |
| Bank of America Corp | 311.5K | -- | 0.64% | +46.9K | 2026-06-30 |
